Slide 1: Third Quarter Update Call
Third Quarter ASP(Sotopes) Update Call NOVEMBER 2025
Slide 2: Forward looking statements
Forward looking statements Forward Looking Statements This presentation contains, and our officers and representatives may from time to time make, “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looki
Slide 3: Senior Management on Today's Call
ASP Isotopes: Senior Management on Today’s Call PAUL MANN ROBERT HEATHER RYNO MICHAEL Executive Chairman AINSCOW KIESSLING PRETORIUS CUNNIFFE Interim Chief Executive Officer Chief Financial Officer Quantum Leap Energy Quantum Leap Energy and Chief Operating Officer Chief Executive Officer Chief Fina
Slide 4: Semiconductor Business Update
Semiconductor Business Update 4 | © ASP Isotopes Inc.
Slide 5: 3Q 2025 Business Update: Silicon-28 Update
ASP Isotopes: 3Q 2025 Business Update Aerodynamic Separation Process (ASP): Silicon-28 Update Silane (Silicon-28) Shipped commercial sample of Silicon-28 to customer. Enrichment level was confirmed and Isotopic purity validated. Our U.S. Semiconductor and Industrial Gas customers for Silicon- 28 vis
Slide 6: 3Q 2025 Business Update: Renergen Virginia Gas Project
ASP Isotopes: 3Q 2025 Business Update Renergen Virginia Gas Project (Pending Acquisition) Awaiting the final regulatory approval for the merger (Financial Surveillance Department of the South African Reserve Bank (FinSurv) as provided for in the South African Exchange Control Regulations - expected
Slide 7: Nuclear Medicine Business Update
Nuclear Medicine Business Update 7 | © ASP Isotopes Inc.
Slide 8: 3Q 2025 Business Update: Quantum Enrichment Isotopes
ASP Isotopes: 3Q 2025 Business Update Quantum Enrichment (QE) Enlightened Isotopes Update First Ytterbium-176 (Yb-176) production plant completed and operational Shipped commercial sample of Yb-176 to customer for independent analysis Delivery of commercial quantity of Yb-176 expected over the cou
Slide 9: 3Q 2025 Business Update: Carbon Update
ASP Isotopes: 3Q 2025 Business Update Aerodynamic Separation Process (ASP): Carbon Update Carbon-12/14 Expect to receive large quantities of feedstock suitable for Carbon-14 production during January 2026 with first shipment of enriched Carbon-14 during 1H 2026. Realigned Carbon-14 feedstock supply
Slide 10: 3Q 2025 Business Update: PET Labs, SPECT, Therapeutics
ASP Isotopes: 3Q 2025 Business Update PET Labs Update Business Update 3Q YoY growth in volumes was 16%, 3Q YoY growth in revenues was 18%. YTD volume growth is 16%, YTD growth in revenues is 24%. New cyclotron now fully operational. Hot cells currently being installed. SPECT Update Shipped first SPE
Slide 11: The Opportunity in Nuclear Energy
The Opportunity in Nuclear Energy 11 | © ASP Isotopes Inc.
Slide 12: Quantum Leap Energy: 3Q 2025 Business Update
Quantum Leap Energy: 3Q 2025 Business Update Quantum Leap Energy Updates Quantum Leap Energy: Commercial Progress Acquired Nuclear Waste Processing Company Acquired “One30Seven” accelerated beta-decay technology. Development of cesium-137 to barium-137 Creber Units underway. Signed Fermi America Mem
Slide 13: Quantum Leap Energy: Strong Momentum & Scalable Growth
Quantum Leap Energy: Strong Momentum & Scalable Growth Our mission is to address gaps in the nuclear fuel cycle, promote safe nuclear power, and enhance the sustainability of the nuclear fuel cycle for advanced nuclear reactors and fusion systems, as well as the existing nuclear fleet. Highlights: R
Slide 14: Quantum Leap Energy: Future-Ready Solutions
Quantum Leap Energy: Future-Ready Solutions Commercial Scale Supply of Critical Materials Lacking in the West. Key Trends: CURRENT EMERGING FUTURE Gen. 2, Gen. 3 Gen. 3+ REACTORS Upgrade of Generation 3 reactors to Gen. 4, Gen. 5 Generation 3+ via LEU+ introduction. Fusion Next Generation Nuclear is
Slide 15: Quantum Leap Energy: Expected Company Development Roadmap
Quantum Leap Energy: Expected Company Development Roadmap Investment Phases: Invest Deliver Accelerate 2025 - 2027 2028 - 2029 2030 > Invest (2025–2027): Significant investment in plant as path to revenue. Demonstration (SA) Legend Deliver (2028–2029): Prove and scale Demonstration (UK) Demonstratio
Slide 16: Skyline Builders Acquisition and Strategy
ASP Isotopes: 3Q 2025 Business Update Skyline Builders Acquisition and Strategy QLE acquired a controlling stake in Skyline Builders Group Holding Limited, a Cayman Islands company with its Class A ordinary shares listed on Nasdaq under the symbol "SKBL". The current business, a construction company
Slide 17: SKBL Proposed Acquisition of SuperCritical
ASP Isotopes: 3Q 2025 Business Update SKBL Proposed Acquisition of SuperCritical SKBL entered into a non-binding Letter of Intent for the acquisition of SuperCritical Technologies Corp. SuperCritical is pioneering a new era in metals production by extracting uranium and critical metals from seawater
Slide 18: Quantum Leap Energy: Capturing a Fragile Nuclear Fuel Line
Quantum Leap Energy: Capturing a Fragile Nuclear Fuel Line Capacity Issues Geopolitical & Operational & Safety Fuel & Reactor Market Risks Risks Constraints Limited capacity Non-NATO oligopolies Logistics and storage Insufficient materials for Concentrated material Materials diverted from hazards ad
Slide 19: Milestones
Milestones 19 | © ASP Isotopes Inc. / Quantum Leap Energy Confidential and Proprietary
Slide 20: ASP Isotopes Future Milestones
ASP Isotopes Future Milestones Future Milestone Targets • Complete our optimization and efficiency plan for the Silicon-28 plant by the end of 2025. • Fulfill all initial commercial contracts of Silicon-28 in 1H 2026. • Ytterbium-176 customer validation and Ytterbium-176 commercial contract fulfillm
Slide 21: Financial Updates
Financial Updates 21 | © ASP Isotopes Inc. / Quantum Leap Energy Confidential and Proprietary
Slide 22: Core Financial Updates - Revenue, Expenses and Cashburn
ASP Isotopes: Core Financial Updates - Revenue, Expenses and Cashburn Revenue (mm) Total Operating Expenses (mm) $8.00 $40.00 $7.00 $35.00 $6.00 $30.00 $15.40 $5.00 $4.90 $25.00 $4.00 $20.00 $3.00 $15.00 $5.70 $12.50 $1.10 $10.00 $2.00 $7.90 $1.20 $1.00 $1.00 $5.00 $8.30 $0.80 $1.10 $6.10 $0.00 $0.0
Slide 23: Other Core Financial Updates
ASP Isotopes: Other Core Financial Updates Cash balance of $113.9 million as of September 30, 2025. This cash balance includes the net proceeds of $56.3 million received during the third quarter from the issuance of ASP Isotopes common stock and $108.0 million YTD from the issuance of ASP Isotopes c
Slide 24: Third Quarter Update Call Q&A
Title Third Quarter Update ⮚ Click to edit Master text styles Call Q&A• Second level NOVEMBER 2025 • Third level – Fourth level » Fifth level 24 | © ASP Isotopes Inc.